Sponsored By

Swiss moldmaker Schöttli acquires U.S. peer Magor

It's a major merger in the medical mold manufacturing market. Mould Technologies Group, parent of Swiss injection moldmaker Schöttli, has acquired Magor Mold. Coupled with its moldmaking business in China, the purchase means the Group now has injection molding capacity across the globe.

PlasticsToday Staff

January 21, 2011

1 Min Read
Swiss moldmaker Schöttli acquires U.S. peer Magor

Magor is based in San Dimas, CA. Schöttli (Diessenhofen, Switzerland) in Oct. 2008 founded a business in Suzhou, China called s-mouldtech. Schöttli and Magor are on the very high end of the injection mold manufacturing business, making high-volume, precision molds for customers in medical, FMCG and other fields. Magor's customers predominantly are processors of medical parts and disposables while Schöttli caters to medical disposable manufacturers as well as to packaging and plastic cap producers. s-mouldtech specializes in injection molds for caps and closures, thin-wall food packaging and cosmetics packaging. Schöttli's molds often figure in high-end molding cells running at trade shows and open house events, as detailed in our coverage of the company. Magor also has been no stranger to our publications.

For the Mould Technologies Group (MTG), adding Magor expands its portfolio particularly with molds for technical parts and functional elements made from engineering plastics. These components are used in medical devices such as diagnostics systems, respirators and application systems. MTG's major stockholders, Wolfgang Bühler, Magor's owner, and Martin Schöttli will remain managing directors of Magor and Schöttli, respectively.

The moldmakers will consolidate their presence in the U.S.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like